Cargando…

Participant experiences using novel home-based blood collection device for viral load testing in the HIV cure trials with analytical treatment interruptions

BACKGROUND: HIV cure-directed clinical trials using analytical treatment interruptions (ATIs) require participants to adhere to frequent monitoring visits for viral load tests. Novel viral load monitoring strategies are needed to decrease participant burden during ATIs. OBJECTIVE: To examine accepta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dubé, Karine, Agarwal, Harsh, Carter, William B., Dee, Lynda, Taylor, Jeff, Roebuck, Christopher, Peterson, Beth, Patel, Hursch, Ndukwe, Samuel, Lynn, Kenneth M., Lalley-Chareczko, Linden, Hiserodt, Emily, Kim, Sukyung, Rosenbloom, Daniel, Evans, Brad R., Anderson, Melanie, Hazuda, Daria J., Bateman, Kevin, Howell, Bonnie J., Azzoni, Livio, Mounzer, Karam, Tebas, Pablo, Montaner, Luis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403870/ https://www.ncbi.nlm.nih.gov/pubmed/35968737

Ejemplares similares

“We are looking at the future right now”: community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States
por: Dubé, Karine, et al.
Publicado: (2022)

Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States
por: Dubé, Karine, et al.
Publicado: (2022)

Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide
por: Lalley-Chareczko, Linden, et al.
Publicado: (2020)

Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection
por: Papasavvas, Emmanouil, et al.
Publicado: (2004)

979. Disparities in PrEP uptake and adherence among cisgender women using a pharmacologic measure
por: Hebel, Shane, et al.
Publicado: (2020)

Interferon-α alters host glycosylation machinery during treated HIV infection
por: Giron, Leila B., et al.
Publicado: (2020)

Prioritizing CD4 Count Monitoring in Response to ART in Resource-Constrained Settings: A Retrospective Application of Prediction-Based Classification
por: Azzoni, Livio, et al.
Publicado: (2012)

Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
por: Giron, Leila B., et al.
Publicado: (2021)

Ethics of HIV cure research: an unfinished agenda
por: Dubé, Karine, et al.
Publicado: (2021)

A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption
por: Peluso, Michael J, et al.
Publicado: (2020)

Re-examining the HIV ‘functional cure’ oxymoron: Time for precise terminology?
por: Dubé, Karine, et al.
Publicado: (2020)

“There’s absolutely no downside to this, I mean, except community opposition:” A qualitative study of the acceptability of vending machines for harm reduction
por: Stewart, Rebecca E., et al.
Publicado: (2023)

Randomized Trial of Time-Limited Interruptions of Protease Inhibitor-Based Antiretroviral Therapy (ART) vs. Continuous Therapy for HIV-1 Infection
por: Firnhaber, Cynthia, et al.
Publicado: (2011)

To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
por: Patel, Hursch, et al.
Publicado: (2023)

Lessons learned from the Last Gift study: ethical and practical challenges faced while conducting HIV cure-related research at the end of life
por: Kanazawa, John, et al.
Publicado: (2023)

Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
por: Dubé, Karine, et al.
Publicado: (2020)

Constitutive Gene Expression in Monocytes from Chronic HIV-1 Infection Overlaps with Acute Toll-Like Receptor Induced Monocyte Activation Profiles
por: Gekonge, Bethsebah, et al.
Publicado: (2012)

Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach
por: Peluso, Michael J, et al.
Publicado: (2020)

645 Structural Bone Deficits in HIV/HCV, HCV-Monoinfected, and HIV-Monoinfected Women
por: Lo Re, Vincent, et al.
Publicado: (2014)

A Correlate of HIV-1 Control Consisting of Both Innate and Adaptive Immune Parameters Best Predicts Viral Load by Multivariable Analysis in HIV-1 Infected Viremic Controllers and Chronically-Infected Non-Controllers
por: Tomescu, Costin, et al.
Publicado: (2014)

Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States
por: Dubé, Karine, et al.
Publicado: (2022)

Ethical and practical considerations for interventional HIV cure-related research at the end-of-life: A qualitative study with key stakeholders in the United States
por: Kanazawa, John, et al.
Publicado: (2021)

Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States
por: Kanazawa, John, et al.
Publicado: (2022)

Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset
por: Azzoni, Livio, et al.
Publicado: (2015)

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
por: Hill, Alison L., et al.
Publicado: (2016)

Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
por: Giron, Leila B., et al.
Publicado: (2021)

Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
por: Hill, Alison L., et al.
Publicado: (2017)

Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk
por: Tebas, Pablo, et al.
Publicado: (2008)

Altruism: Scoping review of the literature and future directions for HIV cure-related research
por: Dubé, Karine, et al.
Publicado: (2020)

Metabolic and anthropometric parameters contribute to ART-mediated CD4(+ )T cell recovery in HIV-1-infected individuals: an observational study
por: Azzoni, Livio, et al.
Publicado: (2011)

Alimentations Europe Interruptibles
por: Campiche, P, et al.
Publicado: (1981)

Identification of a 251 Gene Expression Signature That Can Accurately Detect M. tuberculosis in Patients with and without HIV Co-Infection
por: Dawany, Noor, et al.
Publicado: (2014)

Improved Detection of HIV Gag p24 Protein Using a Combined Immunoprecipitation and Digital ELISA Method
por: Wu, Guoxin, et al.
Publicado: (2021)

Perceived risks and benefits of enrolling people with HIV at the end of life in cure research in Southern California, United States
por: Dubé, Karine, et al.
Publicado: (2023)

Tissue engineering of skin and regenerative medicine for wound care
por: Boyce, Steven T., et al.
Publicado: (2018)

Inhibitors of human immunodeficiency virus type I
por: Hazuda, Daria J
Publicado: (2006)

Interruption science as a research field: Towards a taxonomy of interruptions as a foundation for the field
por: Stangl, Fabian J., et al.
Publicado: (2023)

Interrupts-List
por: Cherix, E
Publicado: (1990)

Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals
por: Yadav, Anjana, et al.
Publicado: (2019)

Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption
por: Ziani, Widade, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uarrpuonqfl3b289bcsvpdl5k1